PurpleLab’s Post

🚨 Pharma product launches have a 40% miss rate. High-stakes investments in new drug launches demand more than traditional targeting methods. At PurpleLab’s recent Decoding Physician Prescribing Behaviour webinar, Theodore Sweetser shared: "If you’re thinking about plowing a billion dollars into go-to-market, 4 out of 10 times, it’s just not going to work out." Why? Because targeting just high-decile prescribers (a.k.a. the “usual suspects”) isn’t enough anymore. The data reveals that nurse practitioners (NPs) and physician assistants (PAs) often have the strongest connections with patients. The takeaway? Pharma marketers need a networked approach: ✅ Understand who’s really shaping prescribing decisions: from diagnosis to treatment. ✅ Use claims data to spot hidden influencers in a patient’s care journey. ✅ Blend digital tools with in-person connections for true omnichannel strategies. As PurpleLab’s Matthew Ryklin highlighted, LLMs and advanced analytics aren’t just buzzwords, they’re game-changers for crafting hyper-specific, data-driven campaigns. Success means broadening your circle, testing and learning quickly, and staying flexible in a rapidly changing healthcare landscape. Curious to learn more? Watch the full webinar for all the insights 👉 https://lnkd.in/dYQ5Yf5P #PharmaMarketing #DataDrivenDecisions #PurpleLab #HealthcareInnovation

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics